AUS
NZ
UK
CA
USA
IND
Healthcare
IXICO PLC Strengthens Neuroimaging and TechBio Expansion
May 25, 2026 12:59 PM BST| By Vivek SinghIXICO PLC advances its TechBio strategy with stronger neuroimaging capabilities, global expansion plans, and growing involvement in Alzheimer’s and Parkinson’s clinical research initiatives.
AstraZeneca Maintains FTSE Presence Through Oncology and Global Healthcare
May 25, 2026 12:14 PM BST| By Vivek SinghAstraZeneca (LSE:AZN) remains active across oncology, respiratory medicine, cardiovascular treatment, and rare disease care with broad pharmaceutical operations spanning the United States, Europe, and Asia.
_05_25_2026_07_30_12_171504.jpg)
London Market Calm Faces a New Test Amid Global Noise
May 25, 2026 08:44 AM BST| By Vivek SinghLondon equities remained resilient as utilities, banks and energy shares responded to commodity movements, retail data and geopolitical developments, while traders closely tracked domestic economic signals and corporate earnings momentum.
Why This UK Index Shake-Up Has the Market Talking
May 25, 2026 08:04 AM BST| By Vivek SinghLondon’s latest benchmark reshuffle saw financial firms move higher while aviation and healthcare names shifted into the mid-cap segment, highlighting how market valuations continue reshaping the UK equity landscape.
Why Are UK Healthcare Stocks Drawing Attention
May 25, 2026 07:27 AM BST| By Vivek SinghAstraZeneca, GSK, Smith & Nephew, and Convatec continue driving healthcare discussion across UK markets through pharmaceutical research, medical technology expansion, and international operations.
![Why are healthcare companies attracting sustained attention across the [FTSE 100]?](https://kalkinemedia.com/storage/uploads/thumbnail/Healthcare,n_05_25_2026_00_46_49_283200.jpg)
Why are healthcare companies attracting sustained attention across the [FTSE 100]?
May 25, 2026 06:52 AM BST| By Vivek SinghHealthcare, banking, energy, industrial, consumer, and technology-linked companies continue supporting strong discussion surrounding UK blue-chip shares connected with the diversified [FTSE 100] market.
Why is AstraZeneca attracting healthcare discussion across the United Kingdom market?
May 25, 2026 06:24 AM BST| By Vivek SinghAstraZeneca continues shaping healthcare discussion across London markets through pharmaceutical research, therapeutic manufacturing, healthcare distribution, and broad medical development activity within the [FTSE 100].
Why has Hikma Pharmaceuticals attracted attention across healthcare discussions?
May 25, 2026 05:06 AM BST| By Vivek SinghHikma Pharmaceuticals remains active across generics, injectables, and branded medicines while broader healthcare discussions connected with United Kingdom benchmark activity continue attracting attention.
Why Is GSK Drawing Attention Across UK Pharma
May 25, 2026 05:06 AM BST| By Vivek SinghPharmaceutical discussions surrounding GSK continue across London trading commentary as healthcare sectors, dividend schedules, and defensive positioning remain visible within broader market conversations.
Why Is Convatec Stock Under Renewed Pressure
May 25, 2026 04:29 AM BST| By Vivek SinghConvatec remained under pressure within the [FTSE 100] as healthcare discussions focused on trading momentum, sector positioning, and broader London market sentiment during recent sessions.
AstraZeneca Expands Healthcare Presence Across FTSE 100 Pharmaceutical
May 24, 2026 07:17 PM BST| By Vivek SinghAstraZeneca continues healthcare activity across pharmaceutical manufacturing, medical research, oncology, respiratory medicine, and biotechnology operations within the UK market environment.
FTSE 100 Rises as Peace Hopes Boost Market Confidence
May 22, 2026 12:54 PM BST| By Vivek SinghUK equities moved higher amid improving diplomatic optimism, while energy prices, inflation concerns, and bond yields continued shaping sentiment across major London-listed sectors.
London Shares Push Higher as Market Mood Brightens
May 22, 2026 12:45 PM BST| By Vivek SinghLondon equities traded higher as softer inflation data, easing geopolitical tensions, and stronger global technology sentiment improved confidence across industrial, financial, healthcare, and energy-linked sectors in the UK market.
IXICO Strengthens Clinical Research Position Through New Agreements
May 21, 2026 12:29 PM BST| By Vivek SinghIXICO PLC (LSE:IXI) advances its neuroscience imaging business through fresh clinical research agreements supporting neurodegenerative disease studies and expanding long-term operational visibility.
IXICO Strengthens Presence Across Neuroscience Imaging Market
May 19, 2026 02:01 PM BST| By Vivek SinghIXICO (LSE:IXI) advances its neuroscience imaging platform with growing contract activity, stronger healthcare partnerships, and expanding opportunities across neurological research and clinical technologies.
Haleon Share Move Sparks Fresh Attention in London Market
May 19, 2026 01:37 PM BST| By Vivek SinghHaleon disclosed a director-linked share acquisition through dividend reinvestment, highlighting ongoing market focus on governance, transparency and shareholder participation across London-listed healthcare companies.
Coiled Therapeutics Strengthens Global Market Presence
May 19, 2026 12:06 PM BST| By Vivek SinghCoiled Therapeutics strengthens its international market presence with a US OTCQB listing while advancing oncology research initiatives and expanding investor accessibility across global markets.
Provexis plc (LSE:PXS) Tracks FTSE Healthcare Market Movement
May 19, 2026 10:43 AM BST| By Vivek SinghProvexis shares reflect healthcare sector activity through research operations, financial frameworks, and product development within the UK equity market.
AstraZeneca (LSE:AZN) Still Drawing Attention in the Pharma Space
May 18, 2026 09:43 AM BST| By Vivek SinghAstraZeneca (LSE:AZN) remains in focus as healthcare innovation, drug development, and global expansion strengthen its position across the pharmaceutical industry and the broader FTSE stock market.
Why GSK’s Latest Executive Share Moves Are Turning Heads
May 15, 2026 12:41 PM BST| By Vivek SinghGSK disclosed routine executive share acquisitions under its reward plan, highlighting leadership alignment, governance transparency, and continued focus on pharmaceuticals, vaccines, and global healthcare operations.
